BioReliance Adds Scientific Experts

BioReliance has added personnel to its Genetic Toxicology and Mammalian Toxicology operations with three scientific experts: Timothy Lawlor, Dr. Rohan Kulkarni and Marie McKeon.
Mr. Lawlor joins the company as director of study management for Genetic Toxicology, managing both principal scientists and study coordination. He has more than 30 years of experience in the CRO industry.

Dr. Kulkarni has been named senior scientist in Genetic Toxicology. Dr. Kulkarni will serve as study director for studies in the in vitro and in vivo Cytogenetics Laboratories. HE recently completed a postdoctoral fellowship at FDA, NCTR (National Center for Toxicological Research) working in Dr. Suzanne Morris’ laboratory.

Ms. McKeon has been named principal scientist in Mammalian Toxicology. As a board certified regulatory toxicologist and the author of numerous publications on in vitro and in vivo toxicology, she will serve as a study director at BioReliance. Ms. McKeon has more than 30 years of experience in toxicology.

“It is with great pleasure that I welcome these new scientists to our team at BioReliance,” said president and chief executive officer, Charles C. Harwood, Jr. “Beginning with the addition of Dr. Marilyn Aardema as chief scientific officer for Toxicology in late 2010, we have continued to expand and enhance our specialized toxicology operations. The expertise added by these newest additions is representative of the quality of our entire staff.”